In Vitro Colorectal Cancer Testing Market USD 800 Million by 2020, Published by iHealthcareAnalyst, Inc.

Maryland Heights, MO, October 20, 2016 --(PR.com)-- The global in vitro colorectal cancer testing market is estimated to reach USD 800 Million in 2020, growing at a CAGR of 9.1% from 2016 to 2020, according to a market research report In vitro Colorectal Cancer Testing Market 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the In vitro Colorectal Cancer Testing Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/in-vitro-colorectal-cancer-testing-market/

The global in vitro colorectal cancer testing market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global in vitro colorectal cancer testing market segmentation is based on test types (Fecal Occult Blood Tests, Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test, Stool Biomarkers Tests, Cologuard, M2-PK Stool Test, Blood Biomarker Tests, ColoSentry, ColoVantage, Epi proColon, mS9), and Product Pipeline (Cologic, Colox, MarCarePlex, MeScore CRC, miRSIGN, PanC – Dx).

The global in vitro colorectal cancer testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global in vitro colorectal cancer testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Test Type
1.1. Fecal Occult Blood Tests
1.1.1.Guaiac FOB Stool Test
1.1.2. Immuno-FOB Agglutination Test
1.1.3. Lateral Flow Immuno-FOB Test
1.1.4. Immuno-FOB ELISA Test
1.2. Stool Biomarkers Tests
1.2.1. Cologuard
1.2.2. M2-PK Stool Test
1.2.3. Other Tests
1.3. Blood Biomarker Tests
1.3.1. ColoSentry
1.3.2. ColoVantage
1.3.3. Epi proColon
1.3.4. mS9
1.3.5. Other Tests

2. Product Pipeline
2.1. Cologic
2.2. Colox
2.3. MarCarePlex
2.4. MeScore CRC
2.5. miRSIGN
2.6. PanC – Dx

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Abbott Laboratories, Inc.
4.2. Alere, Inc.
4.3. Beckman Coulter, Inc.
4.4. Sysmex Corporation
4.5. Quest Diagnostics, Inc
4.6. Epigenomics AG
4.7. Exact Sciences Corporation
4.8. BioTime, Inc.
4.9. CML Healthcare, Inc.
4.10. Novigenix SA

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com